Virus News and Research

Latest Virus News and Research

Cancer patients have higher risk of severe COVID -19 infection than non-cancer patients

Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, a new study from Penn Medicine published online today in JNCI Cancer Spectrum shows.

21 Jan 2021

Arthritis drug is no better than standard care in improving severe COVID-19 outcomes, shows new trial

Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical covid-19 is no better than standard care alone in improving clinical outcomes at 15 days, finds a new trial published by The BMJ today.

20 Jan 2021

Busting myths on airborne transmission of SARS-CoV-2

The rapid spread of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to significant research on the mechanisms of how the virus spreads, which is usually by airborne transmission.

20 Jan 2021

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Renal cell carcinoma (RCC) is the most common form of cancer of the kidney. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney cancer worldwide.

20 Jan 2021

Prioritizing vaccination of high-risk individuals has only a marginal effect, study suggests

The World Health Organization reports that as of January 19, 2021, there are approximately 94 million cases of COVID-19 globally, with over 2 million deaths.

20 Jan 2021

People with problems in the upper GI tract may be vulnerable to COVID-19 infection

No evidence so far indicates that food or drinks can transmit the virus that causes COVID-19, but new research at Washington University School of Medicine in St. Louis suggests that people with problems in the upper gastrointestinal (GI) tract may be vulnerable to infection after swallowing the virus.

20 Jan 2021

COVID-19 has transformed the world of vaccines

Researchers at GlaxoSmithKline (GSK) in Italy and Belgium say the coronavirus disease 2019 (COVID-19) pandemic is transforming the world of vaccinology by accelerating vaccine development and the availability of powerful technologies.

20 Jan 2021

South African SARS-CoV-2 variant escapes antibody neutralization

Researchers in South Africa have conducted a study showing that the novel 501Y.V2 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in the country is able to escape the neutralizing antibodies that are elicited by previously circulating strains of the virus.

20 Jan 2021

Mask-wearing together with social distancing has maximum impact on COVID-19, study finds

A recent study published in the journal The Lancet has revealed that self-reported use of face masks together with social distancing has a considerable impact on controlling the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States.

20 Jan 2021

Ethacrynic acid, a diuretic drug with potential anti-SARS-CoV-2 activity

A study published recently in the journal Viruses has identified a potent diuretic ethacrynic acid as an efficient inhibitor of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This drug can be potentially repurposed to treat coronavirus disease 2019 (COVID-19).

20 Jan 2021

How does SARS-CoV-2 infect brain cells?

Researchers from the University of California San Francisco, Gladstone Institutes in the USA, and The Aga Khan University in Pakistan investigated if human neural cells can be infected by SARS-CoV-2.

20 Jan 2021

Patients fend for themselves to access highly touted covid antibody treatments

By the time he tested positive for covid-19 on Jan. 12, Gary Herritz was feeling pretty sick. He suspects he was infected a week earlier, during a medical appointment in which he saw health workers who were wearing masks beneath their noses or who had removed them entirely.

20 Jan 2021

Can metabolic biomarkers help clinicians stratify adverse outcome risk in COVID-19 patients?

A recent study describes the alterations in lipids and other parameters that define the state of dysfunctional metabolism in acute COVID-19 illness.

20 Jan 2021

Researchers develop new method for charting SARS-CoV-2 spike protein glycosylation

Researchers develop a novel, simple and affordable method for N-glycan fingerprinting based on enzymatic fluorescent glycan labeling and electrophoresis. This new method may help us understand important changes in glycosylation in the SARS-CoV-2 spike protein – something which could inform future therapeutic research.

20 Jan 2021

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

20 Jan 2021

Over 100 million in India may have been infected by SARS-CoV-2

A large new study posted on the preprint server medRxiv describes the seropositivity rate to this virus, as well as the persistence of antibodies over time, both neutralizing and others.

19 Jan 2021

Administration of COVID-19 vaccine may lead to “catastrophic moral failure”, warns WHO

As few as 25 doses of the COVID-19 vaccine have been administered in one of the world's poorest countries, the head of the World Health Organization (WHO) has said, warning of a "catastrophic moral failure".

19 Jan 2021

How COVID-19 changed exercise routines in the UK

A new preprint research paper published on the medRxiv server describes the changes that have taken place in moderate-to-vigorous intensity aerobic physical activity (MVPA) and muscle-strengthening activity (MSA).

19 Jan 2021

The structure dynamics of the SARS-CoV-2 genome in cells, cell lysates and virions

Now, a new preprint research paper posted to the bioRxiv server describes the structures observed during the lifecycle of the RNA virus in terms of both canonical and alternative structures, RNA-RNA interactions, and replication regulation.

19 Jan 2021

Carbon-based nanomaterials as potential COVID-19 treatments

An international team of researchers says that carbon-based nanomaterials (CBNs) could represent promising new approaches to treating coronavirus disease 2019 (COVID-19) pneumonia that is complicated by a secondary bacterial, viral or fungal infection.

19 Jan 2021

Virus News and Research

Latest Virus News and Research

Cancer patients have higher risk of severe COVID -19 infection than non-cancer patients

Arthritis drug is no better than standard care in improving severe COVID-19 outcomes, shows new trial

Busting myths on airborne transmission of SARS-CoV-2

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Prioritizing vaccination of high-risk individuals has only a marginal effect, study suggests

People with problems in the upper GI tract may be vulnerable to COVID-19 infection

COVID-19 has transformed the world of vaccines

South African SARS-CoV-2 variant escapes antibody neutralization

Mask-wearing together with social distancing has maximum impact on COVID-19, study finds

Ethacrynic acid, a diuretic drug with potential anti-SARS-CoV-2 activity

How does SARS-CoV-2 infect brain cells?

Patients fend for themselves to access highly touted covid antibody treatments

Can metabolic biomarkers help clinicians stratify adverse outcome risk in COVID-19 patients?

Researchers develop new method for charting SARS-CoV-2 spike protein glycosylation

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Over 100 million in India may have been infected by SARS-CoV-2

Administration of COVID-19 vaccine may lead to “catastrophic moral failure”, warns WHO

How COVID-19 changed exercise routines in the UK

The structure dynamics of the SARS-CoV-2 genome in cells, cell lysates and virions

Carbon-based nanomaterials as potential COVID-19 treatments

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in